Acessibilidade / Reportar erro

Stained smears as a source of DNA

DIAGNOSIS

RESEARCH NOTE

Stained smears as a source of DNA

Jackeline AlgerII, + + Corresponding author. Fax: (504) 587-7313 ; Martha C AcostaI; Caterin LozanoI; Carmelita VelasquezI; Luz Angela LabradaI

ICorporación CIDEIM, Avenida 1N No.3-03, Cali, Colombia

IIDepartment of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, 1501 Canal Street, New Orleans, Louisiana 70112, USA

Key words:Plasmodium vivax - Mycobacterium tuberculosis - Leishmania (Viannia) panamensis - DNA extraction - PCR - stained-smears

The molecular biological analysis of infectious agents requires the availability of a reliable source of microorganisms to be used to recover DNA. Clinical samples can be obtained directly from infected patients or can be propagated using in vitro or in vivo systems. However, not infrequently, the repeated sampling from patients is not possible because, among other reasons, the procedure is invasive or fastidious, the treatment has been initiated, the patients do not accept the repetition of the procedure or it is not possible to locate them again. Moreover, the in vitro culture of some microorganisms is not possible (e.g. Plasmodium vivax) or requires weeks to months (e.g. Mycobacterium tuberculosis). Neither do all laboratory settings have access to animal models for in vivo systems. Several procedures for DNA extraction from stained specimens and paraffin-embedded tissues have recently been reported. These procedures have yielded DNA from microbial agents in blood stained smears containing P. vivax (RS Witzig, RH Barker 1994 Trans R Soc Trop Med Hyg 88: 198) or P. falciparum parasites (M Kimura et al. 1995 Mol Biochem Parasitol 70: 194-197); stained tissue sections and cytological smears containing, respectively, herpesvirus (GT Nahass et al. 1995 Arch Dermatol 131: 805-808) and human papillomavirus (AM de Roda Husman et al. 1995 Br J Cancer 72: 412-417); and from formalin-fixed, paraffin-embedded tissues containing mycobacteria (HH Popper et al. 1994 Clin Microbiol Infect Dis 101: 738-741, KJ Sung et al. 1993 Internat J Dermatol 32: 710-713) or Leishmania aethiopica (T Laskay et al. 1995 Trans R Soc Trop Med Hyg 89: 273-275). The advantages of such a procedure include: (1) use of the sample to make both the microscopic and the molecular studies, and (2) the possibility of conducting retrospective studies from archival samples, especially from unusual or rare pathologies.

We here report the results of the recovery and amplification of microbial DNA from fixed and stained clinical samples including blood, sputum and tissue fluid.

DNA was extracted from Field-stained P. vivax thick smears (Malaria Control Program Clinic in Florencia, Caqueta and Cali, Colombia), Ziehl-Neelsen-stained sputum smears containing M. tuberculosis (Corporación CIDEIM), and Giemsa-stained smears of tissue fluid and inflammatory exudate containing Leishmania (Viannia) panamensis amastigotes (Corporación CIDEIM) using a 5% (wt/vol) solution of Chelex-100R (K Kain et al. 1992 Am J Trop Med Hyg 46: 473-479, Bio-Rad-Richmond, CA) as follows: 500 ml of 1% Saponin (Sigma-St.Louis, MO) in water was added to 1.5 ml Eppendorf tubes containing sample material obtained by scrapping the surface of the stained smear using a razor blade. Samples were incubated on ice for 60 min, vortexed 3-4 times and centrifuged for 4 min at 12,000 x g at room temperature. After discarding the supernatant, the pellets were washed in PBS (pH 7.2) until the supernatants were clear, usually 2-3 times. Following the addition of 50 µl of 5% (wt/vol) Chelex-100R, the samples were vortexed, incubated at 56ºC for 15 min, vortexed again, and incubated in boiling water for 10 min. After centrifuging at 12,000 x g for 4 min, the supernatant (sometimes colored bluish) was collected and stored at -20ºC until used. Refer to the Table for primer description and amplification conditions. All reactions included the use of 5 µl of extracted DNA and were performed on a MJ Research PTC-100 cycler at Corporación CIDEIM.

All samples containing parasites were amplified by the specific set of primers. The Fig. shows the different PCR products analyzed on agarose gel electrophoresis and stained with ethidium bromide. PCR experiments included the following: purified target DNA, microscopically negative smear, a smear of other etiology, microscopically positive smear, and a reaction control tube (without target DNA). There was not cross contamination as shown by the results obtained with the negative control specimens. We have compared the results obtained by extracting DNA from P. vivax Giemsa-stained thin blood smears and Field-stained thick smears from the same patient and obtained a more intense signal from the thick smear which contains more parasites (data not shown). Similar results were obtained when using stained smears containing different numbers of M. tuberculosis bacilli or Leishmania amastigotes. Furthermore, the different stains did not interfere with the reaction. The use of saponin has improved our results and the PBS washings have not precluded efficient DNA extraction as has been previously reported (Kimura loc.cit). Our results show that stained-smears are a readily available source of DNA of adequate quality and quantity for use in PCR. This resource offers an alternative to molecular studies requiring clinical samples, and facilitates the application of new technologies to diagnosis when microscopy does not allow a sensitive detection or does not allow a complete identification of the etiologic agent.


Acknowledgements: to Dr Nancy G Saravia for insightful review of the manuscript and to the Colombian Malaria Control Program in Caquetá and Cali for their assistance with sample collection.

Received 8 January 1996

Accepted 23 April 1996

This work received financial assistance from UNDP/World Bank/WHO TDR (Grant 930872), and TMRC grant IP50-AI30603 from the U.S. National Institute of Health.

  • +
    Corresponding author. Fax: (504) 587-7313
  • Publication Dates

    • Publication in this collection
      02 Oct 2008
    • Date of issue
      Oct 1996
    Instituto Oswaldo Cruz, Ministério da Saúde Av. Brasil, 4365 - Pavilhão Mourisco, Manguinhos, 21040-900 Rio de Janeiro RJ Brazil, Tel.: (55 21) 2562-1222, Fax: (55 21) 2562 1220 - Rio de Janeiro - RJ - Brazil
    E-mail: memorias@fiocruz.br